✦ LIBER ✦

Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY

✍ Scribed by S. Unniappan; C. H. S. McIntosh; H.-U. Demuth; U. Heiser; R. Wolf; T. J. Kieffer

Publisher: Springer
Year: 2006
Tongue: English
Weight: 231 KB
Volume: 49
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-006-0310-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The influence of hepatic impairment on t

The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin

✍ Y.-L. He; R. Sabo; J. Campestrini; Y. Wang; M. Ligueros-Saylan; K. C. Lasseter; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 240 KB

Neutral endopeptidase 24.11 and dipeptid

Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig

✍ A. Plamboeck; J. J. Holst; R. D. Carr; C. F. Deacon 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 212 KB

Optimization of 1,4-Diazepan-2-one-Conta

Optimization of 1,4-Diazepan-2-one-Containing Dipeptidyl Peptidase IV Inhibitors for the Treatment of Type-2 Diabetes.

✍ Gui-Bai Liang; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views

Regulatory role of adenosine deaminase c

Regulatory role of adenosine deaminase complexing protein (dipeptidyl peptidase IV = CD26) on the malignancy marker adenosine deaminase: Effect of membrane cholesterol and phase-transition

✍ Abraham H. Parola; Valeria R. Caiolfa; Itzhak Ben-Shooshan; Rivka Cohen-Luria 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

While adenosine deaminase (ADA) is an established malignancy marker and its clinical involvement in severe combined immunodeficiency (SCID) is understood, the biological significance of its binding to adenosine deaminase complexing protein (CP = DPPIV = CD26) remains enigmatic. The role of lipid-pro

Distribution of dipeptidyl-peptidase IV

Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers

✍ R. G. van Lingen; M. K. P. Poll; M. M. B. Seyger; E. M. G. J. de Jong; P. C. M. 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 378 KB

The metabolite generated by dipeptidyl-p

The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes

✍ M. Zander; S. Madsbad; C. F. Deacon; J. J. Holst 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 128 KB